Antibody Response to COVID-19 Vaccines in Liver Disease Patients

NCT04775069 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

232

Enrollment

OTHER

Sponsor class

Conditions

Chronic Liver Disease

Interventions

BIOLOGICAL: BNT162b2
BIOLOGICAL: CoronaVac
BIOLOGICAL: AZD1222

Sponsor

Humanity & Health Medical Group Limited